Search

Author/Creator Aisner, Seena C

1. Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial. Issue 12 (December 2017)

Authors:
Wakelee, Heather A; Dahlberg, Suzanne E; Keller, Steven M; Tester, William J; Gandara, David R; Graziano, Stephen L; Adjei, Alex A; Leighl, Natasha B; Aisner, Seena C; Rothman, Jan M; Patel, Jyoti D; Sborov, Mark D; McDermott, Sean R; Perez-Soler, Roman; Traynor, Anne M; Butts, Charles; Evans, Tr...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 12(2017:Dec.)
Page Start:
1610
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial. Issue 12 (December 2016)

Authors:
Neal, Joel W; Dahlberg, Suzanne E; Wakelee, Heather A; Aisner, Seena C; Bowden, Michaela; Huang, Ying; Carbone, David P; Gerstner, Gregory J; Lerner, Rachel E; Rubin, Jerome L; Owonikoko, Taofeek K; Stella, Philip J; Steen, Preston D; Khalid, Ahmed Ali; Ramalingam, Suresh S
Journal:
Lancet oncology
Issue:
Volume 17:Issue 12(2016:Dec.)
Page Start:
1661
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search